Crystal's MCW Coder Hub🧬 ICD-10-CM T38.0X5A — Adverse Effect of Glucocorticoids, Initial Encounter
Billable Code Confirmed — 7 Characters Complete
ICD-10 CM T38.0X5A is a valid, billable 7-character ICD-10-CM code for FY2025. Structure:
T38(hormones) +.0(glucocorticoids) +X(placeholder) +5(adverse effect) +A(initial encounter). Complete and current.
🚨 NEVER SEQUENCE T38.0X5A AS PRINCIPAL DIAGNOSIS
7th Character A vs. D — Know the Difference
🔍 Code Description
ICD-10 CM T38.0X5A classifies the adverse effect of glucocorticoids and synthetic analogues at the initial encounter — the coding mechanism that identifies the drug responsible when a correctly prescribed and correctly administered corticosteroid causes a harmful reaction. This T-code is never a standalone diagnosis — it is the mandatory secondary code that answers the question “what drug caused this?” whenever a steroid-induced complication is documented.
Every steroid-induced glaucoma note in this vault — H40.61X1 through H40.63X2 — carries this code’s companion T38.0X5D as a mandatory additional code on follow-up visits, and T38.0X5A at the initial diagnosis encounter. The T-code transforms those glaucoma codes from generic secondary glaucoma to drug-caused secondary glaucoma in the claim record — a distinction that matters for payer reporting, pharmacovigilance, quality metrics, and longitudinal documentation of the prescribing cascade.
🔑 The Most Critical Concept — Adverse Effect vs. Poisoning
This is among the highest-yield distinctions in all of Chapter 19 and is tested on virtually every AAPC certification exam, including the CIC.
The Three Categories — Know Them Cold
| Category | 6th Character | Clinical Meaning | Sequencing Rule |
|---|---|---|---|
| Adverse Effect | 5 ← T38.0X5A | Drug correctly prescribed + correctly administered → harmful reaction | Code the HARM first, T-code additional |
| Poisoning | 1-4 | Wrong drug / overdose / without prescription / in error | T-code (poisoning) IS the principal; code the harm additional |
| Underdosing | 6 | Patient took less than prescribed | T-code + code the condition that resulted or worsened |
The Core Adverse Effect Test — Two Questions
Ask BOTH questions. Both must be YES for adverse effect:
- Was the drug correctly prescribed by the provider? ✅
- Was it correctly administered (right dose, right route, right frequency)? ✅
If both are YES and harm resulted → adverse effect (6th char “5”) If either is NO → consider poisoning categories instead
For steroid-induced glaucoma and cataracts, the answer is virtually always YES to both — the ophthalmologist, rheumatologist, pulmonologist, or other prescriber ordered the steroid appropriately, and the patient took it as directed. The IOP rise and lens opacity are unwanted but not caused by misuse. → T38.0X5A/D every time.
Poisoning vs. Adverse Effect — Side-by-Side
| Scenario | Category | Code |
|---|---|---|
| Patient on prescribed prednisone → develops steroid glaucoma | Adverse Effect ✅ | H40.61X2 + T38.0X5A/D |
| Patient accidentally takes double dose of prednisone → IOP spikes | Poisoning (accidental) | T38.0X1A (principal) + H40.61X_ (additional) |
| Patient intentionally takes extra prednisone for euphoria → IOP spikes | Poisoning (intentional) | T38.0X2A (principal) + complication |
| Patient on prescribed inhaled fluticasone → develops PSC cataract | Adverse Effect ✅ | H26.13 + T38.0X5A/D |
| Patient given intravitreal triamcinolone → IOP elevation → glaucoma | Adverse Effect ✅ | H40.61X_ + T38.0X5A/D |
| Patient on prescribed dexamethasone → stops taking it too soon | Underdosing | T38.0X6A + worsening condition code |
📊 7th Character — Initial vs. Subsequent vs. Sequela
The 7th character is the most commonly misapplied element of T-codes in coding practice — and it is absolutely tested on the CIC.
A ≠ "First Time Patient Is Seen" — It Means Active Treatment
| 7th Character | Code | Meaning | When to Use |
|---|---|---|---|
| A | T38.0X5A ← THIS CODE | Active treatment phase | First encounter documenting the adverse effect; surgical intervention for the effect; initiation of new treatment regimen |
| D | T38.0X5D | Routine aftercare / follow-up | All ongoing monitoring visits; medication adjustments during stable management |
| S | T38.0X5S | Sequela — late effect | Condition persists AFTER the steroid has been discontinued; the late consequence of the prior exposure |
Real-World 7th Character Application — Steroid Glaucoma Timeline
| Visit | Clinical Event | T-Code |
|---|---|---|
| Visit 1 | Steroid-induced glaucoma first diagnosed — starting latanoprost | T38.0X5A ← Initial encounter |
| Visit 2 | 4-month follow-up — IOP check, HVF monitoring | T38.0X5D ← Subsequent |
| Visit 3 | SLT performed — active surgical intervention | T38.0X5A ← Initial encounter again (new active treatment) |
| Visit 4 | 3-month post-SLT check — IOP stable | T38.0X5D ← Subsequent |
| Visit 5 | Trabeculectomy — filtering surgery | T38.0X5A ← Initial encounter (new active treatment) |
| Visit 6-ongoing | Annual monitoring — steroid stopped years ago, glaucoma persists | T38.0X5S ← Sequela (if steroid stopped) OR T38.0X5D if still on steroid |
T38.0X5A Can Appear Multiple Times in a Patient's History
Unlike some codes that are assigned only once, T38.0X5A can re-appear every time the patient undergoes a new active treatment for the steroid-related condition. Each new surgical intervention (SLT, trabeculectomy, tube shunt) or a NEW adverse effect diagnosis represents an initial encounter. The “A” is not burned once — it resets with each new active treatment episode.
💊 What Drugs Are Covered Under T38.0X5A?
T38.0 (glucocorticoids and synthetic analogues) is a broad category covering systemic AND topical AND inhaled AND intravitreal corticosteroids. If it’s a glucocorticoid — regardless of route — T38.0X5A/D applies.
Glucocorticoids by Route — All Map to T38.0X5
| Drug | Route | Common Clinical Indication | Ophthalmic Complication Risk |
|---|---|---|---|
| Prednisone | Oral, systemic | RA, lupus, IBD, asthma, PMR | High — dose-dependent SIG + PSC |
| Prednisolone | Oral / topical ophthalmic (Pred Forte) | Post-op inflammation, uveitis | High — most common post-surgical SIG trigger |
| Methylprednisolone (Medrol, Solu-Medrol) | Oral, IV, IM | MS flares, transplant, severe inflammation | High — IV bolus → acute IOP spike |
| Dexamethasone (Ozurdex implant) | Intravitreal | DME, RVO, uveitis | Very high — 30-40% IOP spike with implant |
| Triamcinolone acetonide (Kenalog, Triesence) | Intravitreal, sub-Tenon, periocular | DME, BRVO, CRVO, uveitis | High — 20-30% IOP elevation |
| Fluocinolone acetonide (Iluvien, Retisert) | Intravitreal implant | Chronic DME, uveitis | Very high — sustained release → sustained IOP risk |
| Fluticasone (Flonase, Flovent) | Inhaled, intranasal | Asthma, allergic rhinitis | Moderate — systemic absorption → bilateral |
| Budesonide (Pulmicort, Rhinocort) | Inhaled, intranasal | Asthma, Crohn’s disease | Moderate — systemic absorption |
| Mometasone (Nasonex) | Intranasal | Allergic rhinitis | Low-moderate |
| Beclomethasone | Inhaled | Asthma | Moderate |
| Loteprednol (Lotemax) | Topical ophthalmic | Post-op inflammation, allergic conjunctivitis | Lower than prednisolone but still present |
| Hydrocortisone | Topical skin, oral, IV | Skin conditions, adrenal insufficiency | Low topical, higher systemic |
| Betamethasone | Topical skin, IM, epidural | Skin conditions, preterm labor, joint injection | Moderate — joint/epidural route → systemic absorption |
| Cortisone | Oral | Adrenal insufficiency | Moderate |
Mineralocorticoids Are NOT T38.0
Fludrocortisone (Florinef) and aldosterone are mineralocorticoids — they are classified under T50.0 (corticosteroids and synthetic analogues — which covers mineralocorticoids). Do not assign T38.0X5A for fludrocortisone adverse effects.
📋 Sequencing Rules — ICD-10-CM Official Guidelines Section I.C.19.e
The Official Guidelines are explicit and unambiguous on adverse effect sequencing.
The Official Rule — Memorize This for the CIC
“When coding an adverse effect of a drug that has been correctly prescribed and properly administered, assign the appropriate code for the nature of the adverse effect followed by the appropriate adverse effect code.”
Translation:
- Code the condition first — the nature/manifestation of the adverse effect (e.g., H40.61X3 — severe drug-induced glaucoma)
- Code the T-code second — the drug that caused it (e.g., T38.0X5A)
This is the OPPOSITE of poisoning, where the T-code is principal.
Sequencing — Adverse Effect vs. Poisoning Side-by-Side
| Scenario | Principal Code | Additional Code |
|---|---|---|
| Adverse Effect (correct drug/dose) | H40.61X3 — the HARM | T38.0X5A — the DRUG |
| Poisoning (wrong drug/overdose) | T38.0X1A — the DRUG (poisoning) | H40.61X3 — the HARM |
🔗 Related ICD-10-CM Codes
T38.0X5 Family — All Encounters
| Code | Description | Use When |
|---|---|---|
| T38.0X5A | Adverse effect of glucocorticoids, initial encounter ← THIS CODE | First diagnosis; new active treatment; surgical intervention |
| T38.0X5D | Adverse effect of glucocorticoids, subsequent encounter | All routine monitoring/follow-up visits |
| T38.0X5S | Adverse effect of glucocorticoids, sequela | Late effect after steroid discontinued |
Conditions Requiring T38.0X5A/D as Mandatory Additional Code
| Condition Code | Description | Note |
|---|---|---|
| H40.61X1-H40.61X4 | SIG right eye, all stages | ”Use additional code” instruction in tabular |
| H40.62X1-H40.62X4 | SIG left eye, all stages | ”Use additional code” instruction |
| H40.63X1-H40.63X4 | SIG bilateral, all stages | ”Use additional code” instruction |
| H26.13 | Posterior subcapsular cataract | Steroid-induced PSC — T-code appropriate |
| M85.80 | Steroid-induced osteoporosis | Adverse effect of steroids on bone |
| E27.49 | Adrenal insufficiency from steroid withdrawal | Adverse effect — HPA axis suppression |
| L70.0 | Steroid-induced acne | Adverse effect — glucocorticoid-induced |
| E11.649 | Steroid-induced hyperglycemia | Adverse effect — glucocorticoid-induced glucose dysregulation |
T38.0 Poisoning Codes — For Reference (NOT Adverse Effect)
| Code | Description |
|---|---|
| T38.0X1A | Poisoning by glucocorticoids, accidental |
| T38.0X2A | Poisoning by glucocorticoids, intentional self-harm |
| T38.0X3A | Poisoning by glucocorticoids, assault |
| T38.0X4A | Poisoning by glucocorticoids, undetermined |
| T38.0X6A | Underdosing of glucocorticoids |
💊 Coding Scenarios
Scenario 1 — First Diagnosis of Steroid-Induced Glaucoma (Use T38.0X5A ✅)
Clinical Vignette: A 60-year-old male presents to ophthalmology for the first time for IOP concerns. He has been on oral prednisone 20 mg daily for 2 years for RA. IOP OD: 32 mmHg, OS: 30 mmHg. OCT RNFL: bilateral moderate thinning. HVF: bilateral moderate field loss (MD OD -8.2 dB, OS -7.6 dB). Physician: “New diagnosis — bilateral steroid-induced glaucoma, moderate stage. Starting latanoprost OU. Referred back in 6 weeks.”
ICD-10-CM:
- H40.63X2 — Bilateral, moderate (Code First — the nature of the adverse effect)
- T38.0X5A — Adverse effect of glucocorticoids, initial encounter ← FIRST DIAGNOSIS → USE A
- M06.9 — Rheumatoid arthritis (reason for prednisone prescription)
Scenario 2 — 4-Month Monitoring Visit (Use T38.0X5D ✅)
Clinical Vignette: Same patient returns for 4-month monitoring. IOP stable on latanoprost OU. No new symptoms. HVF stable. Routine adjustment — add dorzolamide OS.
ICD-10-CM:
- H40.63X2 — Bilateral, moderate (stable)
- T38.0X5D — Adverse effect of glucocorticoids, subsequent encounter ← FOLLOW-UP → USE D
- M06.9 — RA
Scenario 3 — SLT Performed (T38.0X5A Again — New Active Treatment)
Clinical Vignette: Same patient 1 year later. IOP not at target OS despite three medications. Decision made to perform SLT OS. SLT performed today.
ICD-10-CM:
- H40.62X2 — Left eye, moderate (targeted eye for procedure)
- T38.0X5A — Adverse effect of glucocorticoids, initial encounter ← NEW ACTIVE TREATMENT → USE A AGAIN
- M06.9 — RA
Scenario 4 — Steroid Stopped, Glaucoma Persists (T38.0X5S — Sequela)
Clinical Vignette: A 68-year-old female had steroid-induced glaucoma from 3-year prednisone course for polymyalgia rheumatica. Prednisone discontinued 2 years ago. Glaucoma persists — requires ongoing treatment. IOP controlled on latanoprost. Annual follow-up.
ICD-10-CM:
- H40.61X2 — Right eye, moderate (persistent glaucoma)
- T38.0X5S — Adverse effect of glucocorticoids, sequela ← STEROID STOPPED, EFFECT REMAINS → USE S
- Z87.39 — Personal history of other endocrine, nutritional, and metabolic diseases (or PMR history code)
T38.0X5S — The Forgotten Seventh Character
Sequela (S) is the most underused 7th character in adverse effect coding. When a steroid is no longer being taken but its harmful consequence (glaucoma, cataract, osteoporosis) persists, T38.0X5S is the accurate code — not T38.0X5D. The drug is gone; the damage remains. The T-code with S documents the causal history while acknowledging the condition is now a late effect of prior exposure.
⚠️ Coding Pitfalls and Tips
| Pitfall or Tip | |
|---|---|
| ❌ | Never sequence T38.0X5A as principal diagnosis — the condition caused is ALWAYS listed first; T-code is additional only |
| ❌ | Never use T38.0X5A for poisoning scenarios — wrong drug, overdose, or incorrectly administered → use T38.0X1A-T38.0X4A instead |
| ❌ | Never confuse “initial encounter” with “first visit” — A means active treatment phase, not literally the patient’s first appointment |
| ❌ | Never use T38.0X5A at routine monitoring visits — follow-up → T38.0X5D |
| ❌ | Never apply T38.0 to mineralocorticoids — fludrocortisone → T50.0x series |
| ✅ | T38.0X5A at every NEW active treatment episode — first diagnosis, surgery, new regimen initiation |
| ✅ | T38.0X5D for the long haul — the vast majority of glaucoma monitoring visits over a patient’s lifetime use D |
| ✅ | T38.0X5S when the steroid is gone but the damage remains — sequela coding is accurate and more specific than D at that point |
| ✅ | One T-code covers all affected organs — same T38.0X5D covers both the glaucoma AND the PSC cataract when caused by the same steroid on the same claim |
| ✅ | Covers all routes — oral, IV, intravitreal, sub-Tenon, inhaled, intranasal, topical — any glucocorticoid regardless of route |
| ✅ | Adverse effect vs. poisoning sequencing is CIC exam gold — adverse effect = harm first, T-code second; poisoning = T-code first, harm second |
📚 Sources
1. ICD-10-CM Official Guidelines for Coding and Reporting, FY2025. Section I.C.19.e — Adverse Effects, Poisoning, Underdosing, and Toxic Effects: “When coding an adverse effect of a drug that has been correctly prescribed and properly administered, assign the appropriate code for the nature of the adverse effect followed by the appropriate adverse effect code.” Seventh character definitions: A (initial encounter — active treatment), D (subsequent encounter — routine aftercare), S (sequela).
2. CMS/NCHS. ICD-10-CM Tabular List, Chapter 19, T38.0X5A — Adverse effect of glucocorticoids and synthetic analogues, initial encounter. Non-principal diagnosis sequencing instruction confirmed.
3. AAPC CIC Study Guide — Chapter 19 adverse effect coding, 7th character application, adverse effect vs. poisoning distinction. Sequencing rules confirmed.
4. See vault notes H40.61X1, H40.61X2, H40.61X3, H40.61X4, H40.62X2, H40.63X2 for applied use of T38.0X5A/D as mandatory additional code across all drug-induced glaucoma encounters.